Daniel Glenn Gibson - May 4, 2023 Form 4 Insider Report for Telesis Bio Inc. (TBIO)

Role
Chief Technology Officer
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
May 4, 2023
Transactions value $
-$3,363
Form type
4
Date filed
5/8/2023, 08:09 PM
Previous filing
Aug 8, 2022
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBIO Common Stock Sale -$3.36K -1.19K -1.15% $2.83 102K May 4, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") and does not represent a discretionary sale by the Reporting Person.
F2 Represents the weighted average share price of shares sold in the price range of $2.75 to $2.925 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The reporting person has reported a prior award of RSUs in Table II of Form 4. The total reported in Column 5 includes the 20,910 RSUs previously reported in Table II, and 81,173 shares of common stock.